Meta-analysis of Hsa-mir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993, 75 (5): 843-854.
Wightman B, Ha I, Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993, 75 (5): 855-862.
Mendell JT, Olson EN: MicroRNAs in stress signaling and human disease. Cell. 2012, 148 (6): 1172-1187.
Heinrich EM, Dimmeler S: MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. Circ Res. 2012, 110 (7): 1014-1022.
Boettger T, Braun T: A new level of complexity: the role of microRNAs in cardiovascular development. Circ Res. 2012, 110 (7): 1000-1013.
Cheng W, Liu T, Wan X, Gao Y, Wang H: MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J. 2012, 279 (11): 2047-2059.
Rottiers V, Naar AM: MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012, 13 (4): 239-250.
Grueter CE, van Rooij E, Johnson BA, DeLeon SM, Sutherland LB, Qi X, Gautron L, Elmquist JK, Bassel-Duby R, Olson EN: A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell. 2012, 149 (3): 671-683.
Akbari Moqadam F, Pieters R, den Boer ML: The hunting of targets: challenge in miRNA research. Leukemia. 2013, 27 (1): 16-23.
Vira D, Basak SK, Veena MS, Wang MB, Batra RK, Srivatsan ES: Cancer stem cells, microRNAs, and therapeutic strategies including natural products. Cancer Metastasis Rev. 2012, 31 (3–4): 733-751.
Ebert MS, Sharp PA: Roles for microRNAs in conferring robustness to biological processes. Cell. 2012, 149 (3): 515-524.
Pritchard CC, Cheng HH, Tewari M: MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012, 13 (5): 358-369.
Meister G, Tuschl T: Mechanisms of gene silencing by double-stranded RNA. Nature. 2004, 431 (7006): 343-349.
Yang JS, Lai EC: Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell. 2011, 43 (6): 892-903.
Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ: A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature. 2010, 465 (7298): 584-589.
Cai Y, Yu X, Hu S, Yu J: A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics. 2009, 7 (4): 147-154.
Mishra PJ, Banerjee D, Bertino JR: MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics. Cell Cycle. 2008, 7 (7): 853-858.
Wu C, Gong Y, Sun A, Zhang Y, Zhang C, Zhang W, Zhao G, Zou Y, Ge J: The human MTHFR rs4846049 polymorphism increases coronary heart disease risk through modifying miRNA binding. Nutr Metab Cardiovasc Dis. 2013, 23 (7): 693-698.
Wang K, Li J, Guo H, Xu X, Xiong G, Guan X, Liu B, Chen X, Yang K, Bai Y: MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Carcinogenesis. 2012, 33 (11): 2147-2154.
Luo J, Cai Q, Wang W, Huang H, Zeng H, He W, Deng W, Yu H, Chan E, Ng CF, Huang J, Lin T: A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer. PLoS One. 2012, 7 (6): e40127-
Liu Y, Zhang Y, Wen J, Liu L, Zhai X, Liu J, Pan S, Chen J, Shen H, Hu Z: A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One. 2012, 7 (2): e32230-
Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou C, Zhou J: A miR-200b/200c/429-binding site polymorphism in the 3′ untranslated region of the AP-2alpha gene is associated with cisplatin resistance. PLoS One. 2011, 6 (12): e29043-
Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H: Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2009, 30 (1): 79-84.
Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N, Bugert P, Niederacher D, Meindl A, Schmutzler RK, Bartram CC, Ficarazzi F, Tizzoni L, Zaffaroni D, Manoukian S, Barile M, Pierotti MA, Radice P, Burwinkel B, Peterlongo P: Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. 2010, 31 (1): E1052-E1057.
Omrani M, Hashemi M, Eskandari-Nasab E, Hasani SS, Mashhadi MA, Arbabi F, Taheri M: hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014, 8 (2): 259-267.
Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y, Shen H: A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev. 2009, 18 (4): 1183-1187.
Xu J, Hu Z, Xu Z, Gu H, Yi L, Cao H, Chen J, Tian T, Liang J, Lin Y, Qiu W, Ma H, Shen H, Chen Y: Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat. 2009, 30 (8): 1231-1236.
Zhou B, Rao L, Peng Y, Wang Y, Chen Y, Song Y, Zhang L: Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy. Clin Chim Acta. 2010, 411 (17–18): 1287-1290.
Srivastava K, Srivastava A, Mittal B: Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet. 2010, 55 (8): 495-499.
Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM, Wei Q: Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer. 2010, 116 (20): 4753-4760.
Li LJ, Gao LB, Lv ML, Dong W, Su XW, Liang WB, Zhang L: Association between SNPs in pre-miRNA and risk of chronic obstructive pulmonary disease. Clin Biochem. 2011, 44 (10–11): 813-816.
Zhou J, Lv R, Song X, Li D, Hu X, Ying B, Wei Y, Wang L: Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol. 2012, 31 (4): 524-530.
Yang B, Chen J, Li Y, Zhang J, Li D, Huang Z, Cai B, Li L, Shi Y, Ying B, Wang L: Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population. Hum Immunol. 2012, 73 (1): 101-106.
Zhi H, Wang L, Ma G, Ye X, Yu X, Zhu Y, Zhang Y, Zhang J, Wang B: Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease. Clin Res Cardiol. 2012, 101 (4): 289-296.
Min KT, Kim JW, Jeon YJ, Jang MJ, Chong SY, Oh D, Kim NK: Association of the miR-146aC > G, 149C > T, 196a2C > T, and 499A > G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog. 2012, 51 (Suppl 1): E65-E73.
Chen QH, Wang QB, Zhang B: Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis. Tumour Biol. 2014, 35 (1): 529-543.
Ma XP, Zhang T, Peng B, Yu L, Jiang de K: Association between microRNA polymorphisms and cancer risk based on the findings of 66 case–control studies. PLoS One. 2013, 8 (11): e79584-
Wang PY, Gao ZH, Jiang ZH, Li XX, Jiang BF, Xie SY: The associations of single nucleotide polymorphisms in miR-146a, miR-196a and miR-499 with breast cancer susceptibility. PLoS One. 2013, 8 (9): e70656-
Wang L, Qian S, Zhi H, Zhang Y, Wang B, Lu Z: The association between hsa-miR-499 T > C polymorphism and cancer risk: A meta-analysis. Gene. 2012, 508 (1): 9-14.
Du W, Ma XL, Zhao C, Liu T, Du YL, Kong WQ, Wei BL, Yu JY, Li YY, Huang JW, Li ZK, Liu L: Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility. Asian Pac J Cancer Prev. 2014, 15 (2): 1047-1055.
Wang Y, Yang B, Ren X: Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case–control studies. Gene. 2012, 509 (2): 267-272.
Wang F, Sun G, Zou Y, Li Y, Hao L, Pan F: Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PLoS One. 2012, 7 (9): e45042-
Chen P, Zhang J, Zhou F: miR-499 rs3746444 polymorphism is associated with cancer development among Asians and related to breast cancer susceptibility. Mol Biol Rep. 2012, 39 (12): 10433-10438.
He B, Pan Y, Cho WC, Xu Y, Gu L, Nie Z, Chen L, Song G, Gao T, Li R, Wang S: The association between four genetic variants in MicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One. 2012, 7 (11): e49032-
Wang Z, Cao Y, Jiang C, Yang G, Wu J, Ding Y: Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS One. 2012, 7 (6): e40039-
Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315 (7109): 629-634.
Xiang Y, Fan S, Cao J, Huang S, Zhang LP: Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep. 2012, 39 (6): 7019-7023.
Akkiz H, Bayram S, Bekar A, Akgollu E, Uskudar O: Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case–control study. Asian Pac J Cancer Prev. 2011, 12 (11): 3107-3112.
Kim WH, Min KT, Jeon YJ, Kwon CI, Ko KH, Park PW, Hong SP, Rim KS, Kwon SW, Hwang SG, Kim NK: Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene. 2012, 504 (1): 92-97.
Zou HZ, Zhao YQ: Positive association between miR-499A > G and hepatocellular carcinoma risk in a Chinese population. Asian Pac J Cancer Prev. 2013, 14 (3): 1769-1772.
Shan YF, Huang YH, Chen ZK, Huang KT, Zhou MT, Shi HQ, Song QT, Yu ZP, Deng AM, Zhang QY: miR-499A > G rs3746444 and miR-146aG > C expression and hepatocellular carcinoma risk in the Chinese population. Genet Mol Res. 2013, 12 (4): 5365-5371.
Ma Y, Wang R, Zhang J, Li W, Gao C, Liu J, Wang J: Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population. Genet Test Mol Biomarkers. 2014, 18 (7): 516-524.
Chu YH, Hsieh MJ, Chiou HL, Liou YS, Yang CC, Yang SF, Kuo WH: MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma. PLoS One. 2014, 9 (2): e89930-
Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, Alsaif MA, Alsaif AA: Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One. 2012, 7 (2): e30049-
Ahn DH, Rah H, Choi YK, Jeon YJ, Min KT, Kwack K, Hong SP, Hwang SG, Kim NK: Association of the miR-146aC > G, miR-149 T > C, miR-196a2T > C, and miR-499A > G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog. 2013, 52 (Suppl 1): E39-E51.
Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T, Hirata I: Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter. 2010, 15 (6): 524-531.
Wu XJ, Mi YY, Yang H, Hu AK, Li C, Li XD, Zhang QG: Association of the hsa-mir-499 (rs3746444) polymorphisms with gastric cancer risk in the Chinese population. Onkologie. 2013, 36 (10): 573-576.
Pu JY, Dong W, Zhang L, Liang WB, Yang Y, Lv ML: No association between single nucleotide polymorphisms in pre-mirnas and the risk of gastric cancer in Chinese population. Iranian J Basic Med Sci. 2014, 17 (2): 128-133.
Lv M, Dong W, Li L, Zhang L, Su X, Wang L, Gao L, Zhang L: Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population. J Cancer Res Clin Oncol. 2013, 139 (8): 1405-1410.
Hu X, Li L, Shang M, Zhou J, Song X, Lu X, Wang J, Ying B, Wang L: Association between microRNA genetic variants and susceptibility to colorectal cancer in Chinese population. Tumour Biol. 2014, 35 (3): 2151-2156.
Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, Simi L, Pazzagli M, Orlando C: Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med. 2011, 49 (12): 2073-2080.
Umar M, Upadhyay R, Prakash G, Kumar S, Ghoshal UC, Mittal B: Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer. Mol Carcinog. 2013, 52 (Suppl 1): E10-E18.
Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, Shi Y, Shao A, Tang W, Ding G, Liu C, Chen S, Gu H: MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol. 2013, 74 (9): 1199-1205.
Zhou B, Wang K, Wang Y, Xi M, Zhang Z, Song Y, Zhang L: Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog. 2011, 50 (7): 499-505.
Mittal RD, Gangwar R, George GP, Mittal T, Kapoor R: Investigative role of pre-microRNAs in bladder cancer patients: a case–control study in North India. DNA Cell Biol. 2011, 30 (6): 401-406.
George GP, Gangwar R, Mandal RK, Sankhwar SN, Mittal RD: Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol Biol Rep. 2011, 38 (3): 1609-1615.
Hasani SS, Hashemi M, Eskandari-Nasab E, Naderi M, Omrani M, Sheybani-Nasab M: A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report. Tumour Biol. 2014, 35 (1): 219-225.
Du M, Lu D, Wang Q, Chu H, Tong N, Pan X, Qin C, Yin C, Wang M, Zhang Z: Genetic variations in microRNAs and the risk and survival of renal cell cancer. Carcinogenesis. 2014, 35 (7): 1629-1635.
Hou YY, Lee JH, Chen HC, Yang CM, Huang SJ, Liou HH, Chi CC, Tsai KW, Ger LP: The association between miR-499a polymorphism and oral squamous cell carcinoma progression. Oral Dis. 2014 Apr 2. doi:10.1111/odi.12241. [Epub ahead of print]
Salzman DW, Weidhaas JB: SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacol Ther. 2013, 137 (1): 55-63.
Saunders MA, Liang H, Li WH: Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A. 2007, 104 (9): 3300-3305.
Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005, 433 (7027): 769-773.
Fan C, Chen C, Wu D: The association between common genetic variant of microRNA-499 and cancer susceptibility: a meta-analysis. Mol Biol Rep. 2013, 40 (4): 3389-3394.
Yin Z, Yan L, Cui Z, Li X, Ren Y, Zhou B: Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis. Mol Biol Rep. 2013, 40 (4): 3003-3013.
Hu M, Zhao L, Hu S, Yang J: The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population. PLoS One. 2013, 8 (2): e57012-
Qiu MT, Hu JW, Ding XX, Yang X, Zhang Z, Yin R, Xu L: Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PLoS One. 2012, 7 (12): e50887-
Schaid DJ, Jacobsen SJ: Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol. 1999, 149 (8): 706-711.